Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Jarry

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry|August 6, 2005
8-O-Azeloyl-14-benzoylaconine: a new alkaloid from the roots of Aconitum karacolicum Rapcs and its antiproliferative activitiesAinura Chodoeva, Jean-Jacques Bosc, Jean Guillon, et al.
Investigational New Drugs|June 14, 2013
Antitumor activity of semisynthetic derivatives of Aconitum alkaloidsAinura Chodoeva, Jean-Jacques Bosc, Lydia Lartigue, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Synthesis of new 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents by Suzuki-Miyaura cross-coupling reactionsJean Guillon, Isabelle Forfar, Vanessa Desplat, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Synthesis of new 4-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]quinoxaline and 5-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]thieno[3,2-e]pyrazine derivatives, as potential bacterial multidrug resistance pump inhibitorsCéline Vidaillac, Jean Guillon, Stéphane Moreau, et al.
European Journal of Medicinal Chemistry|June 8, 2012
Hemisynthesis and antiproliferative properties of mono-[O-(14-benzoylaconine-8-yl)]esters and bis-[O-(14-benzoylaconine-8-yl)]estersAinura Chodoeva, Jean-Jacques Bosc, Jean Guillon, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 22, 2006
Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenesViviane Silva Pires, Francois Gaboriau, Jean Guillon, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 29, 2003
Synthesis and initial results for MAO-B inhibition by new N-propargyl-3-pyrrol-1-ylindanamine derivatives, analogues of rasagilineJean Guillon, Guillaume Hébert, Patrick Dallemagne, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 30, 2008
Synthesis of new pyrrolo[1,2-a]quinoxaline derivatives as potential inhibitors of Akt kinaseVanessa Desplat, Ambre Geneste, Marc-Antoine Begorre, et al.
Bioorganic & Medicinal Chemistry|January 3, 2006
Synthesis and preliminary evaluation of new 1- and 3-[1-(2-hydroxy-3-phenoxypropyl)]xanthines from 2-amino-2-oxazolines as potential A1 and A2A adenosine receptor antagonistsStéphane Massip, Jean Guillon, Daniela Bertarelli, et al.
Bioorganic & Medicinal Chemistry|September 30, 2008
New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activityJean Guillon, Stéphane Moreau, Elisabeth Mouray, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|August 6, 2005
8-O-Azeloyl-14-benzoylaconine: a new alkaloid from the roots of Aconitum karacolicum Rapcs and its antiproliferative activitiesAinura Chodoeva, Jean-Jacques Bosc, Jean Guillon, et al.
Investigational New Drugs|June 14, 2013
Antitumor activity of semisynthetic derivatives of Aconitum alkaloidsAinura Chodoeva, Jean-Jacques Bosc, Lydia Lartigue, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Synthesis of new 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents by Suzuki-Miyaura cross-coupling reactionsJean Guillon, Isabelle Forfar, Vanessa Desplat, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Synthesis of new 4-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]quinoxaline and 5-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]thieno[3,2-e]pyrazine derivatives, as potential bacterial multidrug resistance pump inhibitorsCéline Vidaillac, Jean Guillon, Stéphane Moreau, et al.
European Journal of Medicinal Chemistry|June 8, 2012
Hemisynthesis and antiproliferative properties of mono-[O-(14-benzoylaconine-8-yl)]esters and bis-[O-(14-benzoylaconine-8-yl)]estersAinura Chodoeva, Jean-Jacques Bosc, Jean Guillon, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 22, 2006
Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenesViviane Silva Pires, Francois Gaboriau, Jean Guillon, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 29, 2003
Synthesis and initial results for MAO-B inhibition by new N-propargyl-3-pyrrol-1-ylindanamine derivatives, analogues of rasagilineJean Guillon, Guillaume Hébert, Patrick Dallemagne, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 30, 2008
Synthesis of new pyrrolo[1,2-a]quinoxaline derivatives as potential inhibitors of Akt kinaseVanessa Desplat, Ambre Geneste, Marc-Antoine Begorre, et al.
Bioorganic & Medicinal Chemistry|January 3, 2006
Synthesis and preliminary evaluation of new 1- and 3-[1-(2-hydroxy-3-phenoxypropyl)]xanthines from 2-amino-2-oxazolines as potential A1 and A2A adenosine receptor antagonistsStéphane Massip, Jean Guillon, Daniela Bertarelli, et al.
Bioorganic & Medicinal Chemistry|September 30, 2008
New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activityJean Guillon, Stéphane Moreau, Elisabeth Mouray, et al.
Pageof 4